TrialSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2016

Efficacy of palonosetron plus aprepitant in preventing chemoradiotherapy-induced nausea and emesis in patients receiving daily low-dose cisplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a phase II study.

Shinsuke Hanawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.